Movement Alert｜IMPACT THERAP-B rises 6.85% in Regular Trading, buyback plan remains the clearest recent catalyst

Market Focus11-13 11:01

On November 13, IMPACT THERAP-B rose 6.85% in Regular Trading, trading at HK$8.93, with turnover of HK$25.45 million.

The clearest recent catalyst is the company’s previously announced H-share buyback plan of up to HK$100 million, which had already triggered a double-digit opening move earlier this month and is still being cited in market reports as a direct support for sentiment and valuation.

According to the company’s announcement, the board resolved to repurchase H shares on the Hong Kong Stock Exchange under the general mandate approved at the June 25 annual general meeting, with total buybacks not exceeding HK$100 million including transaction costs. The company also said the timing, quantity and price of any repurchases will depend on market conditions and remain at the board’s discretion, with no assurance that any buyback will necessarily be executed.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment